학술논문
Humoral Response and Safety after a Fourth Dose of the SARS-CoV-2 BNT162b2 Vaccine in Cancer Patients Undergoing Active Treatment—Results of a Prospective Observational Study
Document Type
Article
Author
Source
In: Vaccines . (Vaccines, January 2024, 12(1))
Subject
Language
English
ISSN
2076393X